List of Tables
Table 1 Embolotherapy Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 2 Neurovascular Coils Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 3 Number of Neurovascular Coils Units Sold Globally, Based on Region (2021-2029) (Nos)
Table 4 Intracranial Aneurysm Global Procedural Volume, Based on Region, (2021-2029) ($Mn)
Table 5 Neurovascular Coil Units Sold and Intracranial Aneurysm Procedures, Based on Countries (2022) (Nos)
Table 6 Embolotherapy Global Market Revenue, Based on Products (2021-2029) ($Mn)
Table 7 Temporary Agents Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 8 Temporary Agents Global Market Revenue, Based on Product (2021-2029) ($Mn)
Table 9 Autologous Agents Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 10 Resorbable Gelatin Sponge Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 11 Permanent Agents Global Market Revenue, Based on Products, (2021-2029) ($Mn)
Table 12 Permanent Agents Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 13 Particle Agents Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 14 Particle Agents Global Market Revenue, Based on Products (2021-2029) ($Mn)
Table 15 Polyvinyl Alcohol (Pva) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 16 Microspheres Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 17 Coils Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 18 Coils Global Market Revenue, Based on Deployment (2021-2029) ($Mn)
Table 19 Pushable Coils Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 20 Detachable Coils Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 21 Liquid Embolization Agents Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 22 Flow Diverters & Flow Disruptors Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 23 Other Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 24 Radioembolization Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 25 Supporting Devices Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 26 Embolotherapy Global Market Revenue, Based on Application (2021-2029) ($Mn)
Table 27 Neurology Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 28 Neurology Global Market Revenue, Based on Indication (2021-2029) ($Mn)
Table 29 Intracranial Aneurysm Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 30 Arteriovenous Malformations (Avm) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 31 Oncology Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 32 Oncology Global Market Revenue, Based on Indication (2021-2029) ($Mn)
Table 33 Liver Cancer Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 34 Lung Cancer Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 35 Other Cancer Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 36 Peripheral Vascular Diseases (Pvd) Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 37 Urology Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 38 Other Applications Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 39 Embolotherapy Global Market Revenue, Based on Procedure (2021-2029) ($Mn)
Table 40 Transcatheter Arterial Embolization (Tae) Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 41 Transcatheter Arterial Chemoembolization (Tace) Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 42 Transcatheter Arterial Chemoembolization (Tace) Global Market Revenue, Based on Therapy Agent (2021-2029) ($Mn)
Table 43 Drug-Eluting Beads Transcatheter Arterial Chemoembolization (Deb-Tace)Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 44 Conventional Transarterial Chemo-Embolization (Ctace) Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 45 Selective Internal Radiation Therapy (Sirt) Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 46 Tae and Deb-Tace Products Matrix
Table 47 Embolotherapy Global Market Revenue, Based on End-User (2021-2029) ($Mn)
Table 48 Hospital Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 49 Ambulatory Surgical Centers Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 50 Other End-User Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 51 Embolotherapy Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 52 North American Embolotherapy Market Revenue, Based on Products (2021-2029) ($Mn)
Table 53 North American Temporary Agents Market Revenue, Based on Products (2021-2029) ($Mn)
Table 54 North American Permanent Agents Market Revenue, Based on Products (2021-2029) ($Mn)
Table 55 North American Particle Agents Market Revenue, Based on Products (2021-2029) ($Mn)
Table 56 North American Coils Market Revenue, Based on Deployment (2021-2029) ($Mn)
Table 57 North American Embolotherapy Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 58 North American Neurology Market Revenue, Based on Indication (2021-2029) ($Mn)
Table 59 North American Oncology Market Revenue, Based on Indication, (2021-2029) ($Mn)
Table 60 North American Embolotherapy Market Revenue, Based on Procedure, (2021-2029) ($Mn)
Table 61 North American Tace Market Revenue, Based on Therapy Agent (2021-2029) ($Mn)
Table 62 North American Embolotherapy Market Revenue, Based on End-User (2021-2029) ($Mn)
Table 63 North America Embolotherapy Market Revenue, Based on Country (2021-2029) ($Mn)
Table 64 European Embolotherapy Market Revenue, Based on Products (2021-2029) ($Mn)
Table 65 European Temporary Agents Market Revenue, Based on Products (2021-2029) ($Mn)
Table 66 European Permanent Agents Market Revenue, Based on Products (2021-2029) ($Mn)
Table 67 European Particle Agents Market Revenue, Based on Products (2021-2029) ($Mn)
Table 68 European Coils Market Revenue, Based on Deployment (2021-2029) ($Mn)
Table 69 European Embolotherapy Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 70 European Neurology Market Revenue, Based on Indication (2021-2029) ($Mn)
Table 71 European Oncology Market Revenue, Based on Indication, (2021-2029) ($Mn)
Table 72 European Embolotherapy Market Revenue, Based on Procedure, (2021-2029) ($Mn)
Table 73 European Tace Market Revenue, Based on Therapy Agent (2021-2029) ($Mn)
Table 74 Europe Embolotherapy Market Revenue, Based on End-User (2021-2029) ($Mn)
Table 75 European Embolotherapy Market Revenue, Based on Country (2021-2029) ($Mn)
Table 76 Asia-Pacific Embolotherapy Market Revenue, Based on Products (2021-2029) ($Mn)
Table 77 Asia-Pacific Temporary Agents Market Revenue, Based on Product (2021-2029) ($Mn)
Table 78 Asia-Pacific Permanent Agents Market Revenue, Based on Products (2021-2029) ($Mn)
Table 79 Asia-Pacific Particle Agents Market Revenue, Based on Products (2021-2029) ($Mn)
Table 80 Asia-Pacific Coils Market Revenue, Based on Deployment (2021-2029) ($Mn)
Table 81 Asia-Pacific Embolotherapy Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 82 Asia-Pacific Neurology Market Revenue, Based on Indication (2021-2029) ($Mn)
Table 83 Asia-Pacific Oncology Market Revenue, Based on Indication, (2021-2029) ($Mn)
Table 84 Asia-Pacific Embolotherapy Market Revenue, Based on Procedure, (2021-2029) ($Mn)
Table 85 Asia-Pacific Tace Market Revenue, Based on Therapy Agent (2021-2029) ($Mn)
Table 86 Asia-Pacific Embolotherapy Market Revenue, Based on End-User (2021-2029) ($Mn)
Table 87 Asia-Pacific Embolotherapy Market Revenue, Based on Country (2021-2029) ($Mn)
Table 88 RoW Embolotherapy Market Revenue, Based on Products (2021-2029) ($Mn)
Table 89 RoW Temporary Agents Market Revenue, Based on Product (2021-2029) ($Mn)
Table 90 RoW Permanent Agents Market Revenue, Based on Products (2021-2029) ($Mn)
Table 91 RoW Particle Agents Market Revenue, Based on Products (2021-2029) ($Mn)
Table 92 RoW Coils Market Revenue, Based on Deployment (2021-2029) ($Mn)
Table 93 RoW Embolotherapy Market Revenue, Based on Application, (2021-2029) ($Mn)
Table 94 RoW Neurology Market Revenue, Based on Indication (2021-2029) ($Mn)
Table 95 RoW Oncology Market Revenue, Based on Indication, (2021-2029) ($Mn)
Table 96 RoW Embolotherapy Market Revenue, Based on Procedure, (2021-2029) ($Mn)
Table 97 RoW Tace Market Revenue, Based on Therapy Agents (2021-2029) ($Mn)
Table 98 RoW Embolotherapy Market Revenue, Based on End-User (2021-2029) ($Mn)
Table 99 RoW Embolotherapy Market Revenue, Based on Country (2021-2029) ($Mn)
Table 100 Approvals (2020-2022)
Table 101 Acquisition (2020-2022)
Table 102 Agreements (2020-2022)
Table 103 New Product Launch (2020-2022)
Table 104 Others (2020-2022)
Table 105 Boston Scientific Corp.: Total Revenue and R&D Expenses, (2020-2022)(Q3) ($Mn)
Table 106 Boston Scientific Corp.: Total Revenue, Based on Segments, (2020-2022)(Q3) ($Mn)
Table 107 Boston Scientific Corp.: Cardiovascular Sub-Segment Total Revenue, (2022)(Q3) ($Mn)
Table 108 Boston Scientific Corp.: Total Revenue, Based on Geography, (2020-2022) (Q3) ($Mn)
Table 109 Johnson & Johnson: Total Revenue and R&D Expenses, (2020-2022) (Q2)($Mn)
Table 110 Johnson & Johnson: Total Revenue, Based on Segments, (2020-2022) (Q2) ($Mn)
Table 111 Johnson & Johnson: Total Revenue, Based on Geography, (2020-2022) (Q2) ($Mn)
Table 112 Kaneka Corporation: Total Revenue and R&D Expenses, (2020-2022) (Q2) ($Mn)
Table 113 Kaneka Corporation: Total Revenue, Based on Segments, (2020-2022) (Q2) ($Mn)
Table 114 Kaneka Corporation: Total Revenue, Based on Geography, (2020-2022) (Q2) ($Mn)
Table 115 Medtronic, plc: Total Revenue and R&D Expenses, (2020-2022) (Q2) ($Mn)
Table 116 Medtronic, plc: Total Revenue, Based on Segments, (2020-2022) (Q2) ($Mn)
Table 117 Medtronic, plc: Cardiovascular Total Revenue, Based on Sub-Segments, (2020-2022) (Q2) ($Mn)
Table 118 Medtronic, plc: Neurosciences Total Revenue, Based on Sub-Segments, (2020-2022) (Q2) ($Mn)
Table 119 Medtronic, plc: Total Revenue, Based on Geography, (2020-2022) (Q2) ($Mn)
Table 120 Merit Medical Systems, Inc: Total Revenue and R&D Expenses, (2020-2022)(Q3) ($Mn)
Table 121 Merit Medical Systems, Inc: Total Revenue, Based on Segments, (2020-2022) (Q3) ($Mn)
Table 122 Merit Medical Systems, Inc: Cardiovascular Total Revenue, Based on Sub-Segments, (2020-2022)(Q3) ($Mn)
Table 123 Merit Medical Systems, Inc: Total Revenue, Based on Geography, (2020-2022)(Q3) ($Mn)
Table 124 Penumbra, Inc: Total Revenue and R&D Expenses, (2020-2022) (Q3) ($Mn)
Table 125 Penumbra, Inc: Total Revenue, Based on Segments, (2020-2022) (Q3) ($Mn)
Table 126 Penumbra, Inc.: Total Revenue, Based on Geography, (2020-2022) (Q3)($Mn)
Table 127 Stryker Corporation: Total Revenue and R&D Expenses, (2020-2022) (Q3) ($Mn)
Table 128 Stryker Corporation: Total Revenue, Based on Segments, (2020-2022) (Q3) ($Mn)
Table 129 Stryker Corporation: Total Revenue, Based on Sub-Segments, (2020-2022)(Q3) ($Mn)
Table 130 Stryker Corporation: Total Revenue, Based on Geography, (2020-2022) (Q3) ($Mn)
Table 131 Terumo Corporation: Total Revenue and R&D Expenses, (2020-2022) (Q2) ($Mn)
Table 132 Terumo Corporation: Total Revenue, Based on Segments, (2020-2022) (Q2) ($Mn)
Table 133 Terumo Corporation: Total Revenue, Based on Geography, (2020-2022) (Q2) ($Mn)
List of Figures
Figure 1 Embolotherapy Global Market Revenue, Based on Region (2021-2029) ($Mn)
Figure 2 Research Methodology: Embolotherapy Global Market
Figure 3 Embolotherapy Global Market: Top-Down and Bottom-Up Approach
Figure 4 Embolotherapy Global Market: Forecasting Model
Figure 5 Embolotherapy Global Market: Market Breakdown and Data Triangulation
Figure 6 Embolotherapy Global Market Segmentation
Figure 7 Embolotheapy Products Global Market Segmentation
Figure 8 Embolotheapy Application Global Market Segmentation
Figure 9 Embolotheapy Procedures Global Market Segmentation
Figure 10 Market Dynamics
Figure 11 Embolotherapy Global Market: Porter's Analysis
Figure 12 Clinical Trials of Embolotherapy Based on Phases
Figure 13 Clinical Trials of Embolotherapy Based on Condition
Figure 14 Embolotherapy Global Market Share Analysis by Major Players, 2022 (%)
Figure 15 Coils Global Market Share Analysis by Major Players, 2022 (%)
Figure 16 Flow Diverters & Disruptors Global Market Share Analysis by Major Players, 2022 (%)
Figure 17 Radioembolization Global Market Share Analysis by Major Players, 2022 (%)
Figure 18 Neurovascular Coils No. Of Units Sold, Based on Region and Countries, (2022) (Nos)
Figure 19 Intracranial Aneurysm No. Of Procedures, Based on Region and Countries, (2022) (Nos)
Figure 20 Embolotheapy Global Market Share, Based on Product, (2022 V/S 2029) (%)
Figure 21 Temporary Agents Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 22 Temporary Agents Global Market Share, Based on Products (2022 V/S 2029) (%)
Figure 23 Resorbable Gelatin Sponge Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 24 Permanent Agents Global Market Share, Based on Product, (2022 V/S 2029) (%)
Figure 25 Permanent Agents Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 26 Particle Agents Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 27 Particle Agents Global Market Share, Based on Products (2022 V/S 2029) (%)
Figure 28 Polyvinyl Alcohol (Pva) Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 29 Coils Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 30 Coils Global Market Share, Based on Deployment (2022 V/S 2029) (%)
Figure 31 Pushable Coils Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 32 Detachable Coils Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 33 Liquid Embolization Agents Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 34 Embolotherapy Global Market Share, Based on Application (2022) (%)
Figure 35 Neurology Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 36 Neurology Global Market Share, Based on Indication (2022 V/S 2029) (%)
Figure 37 Intracranial Aneurysm Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 38 Arteriovenous Malformations (Avm) Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 39 Oncology Global Market Share, Based on Indication (2022 V/S 2029) (%)
Figure 40 Peripheral Vascular Diseases (Pvd) Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 41 Embolotherapy Global Market Share, Based on Procedure, (2022 V/S 2029) (%)
Figure 42 Transcatheter Arterial Embolization (Tae) Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 43 Transcatheter Arterial Chemoembolization (Tace) Global Market Share, Based on Therapy Agent, (2022 V/S 2029) (%)
Figure 44 Conventional Transarterial Chemo-Embolization (Ctace) Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 45 Embolotherapy Global Market Share, Based on End-User (2022 V/S 2029) (%)
Figure 46 Hospitals Global Market Share, Based on Region, (2022 V/S 2029) (%)
Figure 47 Embolotherapy Global Market Revenue, Based on Region (2021-2029) ($Mn) CAGR (%)
Figure 48 Embolotherapy Global Market Share, Based on Regional Market Revenue (2022) (%) ($Mn)
Figure 49 North American Embolotherapy Market Share, Based on Product, (2022 V/S 2029) (%)
Figure 50 North American Temporary Agents Market Share, Based on Product (2022 V/S 2029) (%)
Figure 51 North American Permanent Agents Market Share, Based on Products (2022 V/S 2029) (%)
Figure 52 North American Particle Agents Market Share, Based on Products (2022 V/S 2029) (%)
Figure 53 North America Coils Market Share, Based on Deployment, (2022 V/S 2029) (%)
Figure 54 North American Embolotherapy Market Share, Based on Application, (2022) (%)
Figure 55 North American Neurology Market Share, Based on Indication, (2022 V/S 2029) (%)
Figure 56 North American Embolotherapy Market Share, Based on Indication, (2022 V/S 2029) (%)
Figure 57 North American Embolotherapy Market Share, Based on Procedure, (2022 V/S 2029) (%)
Figure 58 North American Tace Market Share, Based on Therapy Agents, (2022 V/S 2029) (%)
Figure 59 North American Embolotherapy Market Share, Based on End-User (2022 V/S 2029) (%)
Figure 60 North America Embolotherapy Market Share, Based on Country (2022 V/S 2029) (%)
Figure 61 U.S. Embolotherapy Market Revenue, Based on Product and Application (2022 V/S 2029) ($Mn)
Figure 62 U.S. Embolotherapy Market Revenue, Based on Procedure and End-User (2022 V/S 2029) ($Mn)
Figure 63 Rest of North America Embolotherapy Market Revenue, Based on Product and Application (2022 V/S 2029) ($Mn)
Figure 64 Rest North America Embolotherapy Market Revenue, Based on Procedure and End-User (2022 V/S 2029) ($Mn)
Figure 65 European Embolotherapy Market Share, Based on Product, (2022 V/S 2029) (%)
Figure 66 European Temporary Agents Market Share, Based on Products (2022 V/S 2029) (%)
Figure 67 European Permanent Agents Market Share, Based on Products (2022 V/S 2029) (%)
Figure 68 European Particle Agents Market Share, Based on Products (2022 V/S 2029) (%)
Figure 69 European Coils Market Share, Based on Deployment, (2022 V/S 2029) (%)
Figure 70 European Embolotherapy Market Share, Based on Application, (2022) (%)
Figure 71 European Neurology Market Share, Based on Indication, (2022 V/S 2029) (%)
Figure 72 European Oncology Market Share, Based on Indication, (2022 V/S 2029) (%)
Figure 73 European Embolotherapy Market Share, Based on Procedure, (2022 V/S 2029) (%)
Figure 74 European Tace Market Share, Based on Therapy Agents, (2022 V/S 2029) (%)
Figure 75 European Embolotherapy Market Share, Based on End-User (2022 V/S 2029) (%)
Figure 76 European Embolotherapy Market Share, Based on Country (2022 V/S 2029) (%)
Figure 77 Germany Embolotherapy Market Revenue, Based on Products and Application (2022 V/S 2029) ($Mn)
Figure 78 Germany Embolotherapy Market Revenue, Based on Procedure and End-Users (2022 V/S 2029) ($Mn)
Figure 79 France Embolotherapy Market Revenue, Based on Products and Application (2022 V/S 2029) ($Mn)
Figure 80 France Embolotherapy Market Revenue, Based on Procedure and End-Users (2022 V/S 2029) ($Mn)
Figure 81 Italy Embolotherapy Market Revenue, Based on Products and Application (2022 V/S 2029) ($Mn)
Figure 82 Italy Embolotherapy Market Revenue, Based on Procedure and End-Users (2022 V/S 2029) ($Mn)
Figure 83 Rest of Europe Embolotherapy Market Revenue, Based on Products and Application (2022 V/S 2029) ($Mn)
Figure 84 Rest of Europe Embolotherapy Market Revenue, Based on Procedure and End-Users (2022 V/S 2029) ($Mn)
Figure 85 Asia-Pacific Embolotherapy Market Share, Based on Product, (2022 V/S 2029) (%)
Figure 86 Asia-Pacific Temporary Agents Market Share, Based on Product (2022 V/S 2029) (%)
Figure 87 Asia-Pacific Permanent Agents Market Share, Based on Products (2022 V/S 2029) (%)
Figure 88 Asia-Pacific Particle Agents Market Share, Based on Products (2022 V/S 2029) (%)
Figure 89 Asia-Pacific Coils Market Share, Based on Deployment, (2022 V/S 2029) (%)
Figure 90 Asia-Pacific Embolotherapy Market Share, Based on Application, (2022) (%)
Figure 91 Asia-Pacific Neurology Market Share, Based on Indication, (2022 V/S 2029) (%)
Figure 92 Asia-Pacific Embolotherapy Market Share, Based on Indication, (2022 V/S 2029) (%)
Figure 93 Asia-Pacific Embolotherapy Market Share, Based on Procedure, (2022 V/S 2029) (%)
Figure 94 Asia-Pacific Tace Market Share, Based on Therapy Agents, (2022 V/S 2029) (%)
Figure 95 Asia-Pacific Embolotherapy Market Share, Based on End-User (2022 V/S 2029) (%)
Figure 96 Asia-Pacific Embolotherapy Market Share, Based on Country (2022 V/S 2029) (%)
Figure 97 Japan Embolotherapy Market Revenue, Based on Products and Application (2022 V/S 2029) ($Mn)
Figure 98 Japan Embolotherapy Market Revenue, Based on Procedure and End-Users (2022 V/S 2029) ($Mn)
Figure 99 China Embolotherapy Market Revenue, Based on Products and Application (2022 V/S 2029) ($Mn)
Figure 100 China Embolotherapy Market Revenue, Based on Procedure and End-Users (2022 V/S 2029) ($Mn)
Figure 101 India Embolotherapy Market Revenue, Based on Product and Application (2022 V/S 2029) ($Mn)
Figure 102 India Embolotherapy Market Revenue, Based on Procedure and End-User (2022 V/S 2029) ($Mn)
Figure 103 Rest of APAC Embolotherapy Market Revenue, Based on Products and Application (2022 V/S 2029) ($Mn)
Figure 104 Rest of APAC Embolotherapy Market Revenue, Based on Procedure and End-Users (2022 V/S 2029) ($Mn)
Figure 105 RoW Embolotherapy Market Share, Based on Products, (2022 V/S 2029) (%)
Figure 106 RoW Temporary Agents Market Share, Based on Product (2022 V/S 2029) (%)
Figure 107 RoW Permanent Agents Market Share, Based on Products (2022 V/S 2029) (%)
Figure 108 RoW Particle Agents Market Share, Based on Products (2022 V/S 2029) (%)
Figure 109 RoW Coils Market Share, Based on Deployment, (2022 V/S 2029) (%)
Figure 110 RoW Embolotherapy Market Share, Based on Application, (2022) (%)
Figure 111 RoW Neurology Market Share, Based on Indication, (2022 V/S 2029) (%)
Figure 112 RoW Embolotherapy Market Share, Based on Indication, (2022 V/S 2029) (%)
Figure 113 RoW Embolotherapy Market Share, Based on Procedure, (2022 V/S 2029) (%)
Figure 114 RoW Tace Market Share, Based on Therapy Agents, (2022 V/S 2029) (%)
Figure 115 RoW Embolotherapy Market Share, Based on End-User (2022 V/S 2029) (%)
Figure 116 RoW Embolotherapy Market Share, Based on Country (2022 V/S 2029) (%)
Figure 117 Brazil Embolotherapy Market Revenue, Based on Products and Application (2022 V/S 2029) ($Mn)
Figure 118 Brazil Embolotherapy Market Revenue, Based on Procedure and End-Users (2022 V/S 2029) ($Mn)
Figure 119 Rest of South America Embolotherapy Market Revenue, Based on Products and Application (2022 V/S 2029) ($Mn)
Figure 120 Rest of South America Embolotherapy Market Revenue, Based on Procedure and End-Users (2022 V/S 2029) ($Mn)
Figure 121 Middle East and Africa Embolotherapy Market Revenue, Based on Products and Application (2022 V/S 2029) ($Mn)
Figure 122 Middle East and Africa Embolotherapy Market Revenue, Based on Procedure and End-User (2022 V/S 2029) ($Mn)
Figure 123 Key Growth Strategies (2020-2022)
Figure 124 Swot: Balt Group
Figure 125 Swot: Boston Scientific Corporation
Figure 126 Swot: Sirtex Medical Inc.
Figure 127 Swot: Johnson & Johnson
Figure 128 Swot: Kaneka Corporation
Figure 129 Swot: Medtronic, plc
Figure 130 Swot: Merit Medical Systems, Inc.
Figure 131 Swot: Penumbra
Figure 132 Swot: Stryker
Figure 133 Swot: Terumo Corporation